Literature DB >> 26155556

Expression of Proliferating Cell Nuclear Antigen (PCNA) in Oral Submucous Fibrosis: An Immunohistochemical Study.

Roopavathi Keshav1, Umashree Narayanappa2.   

Abstract

BACKGROUND AND OBJECTIVES: Expression of Proliferating Cell Nuclear Antigen (PCNA) well-correlates with the cell division. The suprabasal expression of PCNA is considered to be a marker of dysplastic oral mucosa indicating a special proliferative cellular state in those lesions. Oral submucous fibrosis (OSMF) is considered to be a premalignant condition with potential to get transformed into oral squamous cell carcinoma (OSCC). The present study was done to assess the PCNA expression in different grades and in different layers of epithelium of OSMF and to compare the expression of PCNA in OSMF with OSCC.
MATERIALS AND METHODS: A group of 40 histopathologically diagnosed, formalin fixed, paraffin embedded tissue samples were included in study. The study group was further divided into 2 groups; 30 OSMF and 10 OSCC. Theses samples were collected from Department of Oral and Maxillofacial Pathology, Government Dental College and Research Institute, Bangalore. The samples were subjected to immunohistochemical method using indirect immunoenzyme LSAB method.
RESULTS: All 40 cases showed positivity for PCNA. The percentage of positive cells was more in basal and suprabasal layer both in OSMF and OSCC, whereas the greater percentage of positive cells was seen in the superficial layer of OSCC. All OSMF cases showed positive expression in basal and suprabasal layer and only 77% of cases showed positive PCNA expression in the superficial layer with variable immunoreactivity and 23% did not show any positive staining in the superficial layer. The percentage of positive cells and the intensity of staining increased as the disease severity increased in OSMF.
CONCLUSION: Increased proportion of cells expressed PCNA staining which are in proliferative layers of OSMF. This biomarker provides an insight into the biological behaviour of the condition that substantiates its potentially malignant nature and may also provide an intermediate end point in chemotherapeutic trials.

Entities:  

Keywords:  Biomarker; Malignant potential; Oral squamous cell carcinoma; Proliferative pool

Year:  2015        PMID: 26155556      PMCID: PMC4484148          DOI: 10.7860/JCDR/2015/13046.5885

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  24 in total

1.  Cancer of the buccal mucosa; a clinical study of 650 cases in Indian patients.

Authors:  J C PAYMASTER
Journal:  Cancer       Date:  1956 May-Jun       Impact factor: 6.860

Review 2.  Oral submucous fibrosis. A review.

Authors:  S C Cox; D M Walker
Journal:  Aust Dent J       Date:  1996-10       Impact factor: 2.291

3.  Quantitative estimation of PCNA, c-myc, EGFR and TGF-alpha in oral submucous fibrosis--an immunohistochemical study.

Authors:  M Srinivasan; S D Jewell
Journal:  Oral Oncol       Date:  2001-07       Impact factor: 5.337

4.  Clinical and functional staging of oral submucous fibrosis.

Authors:  S M Haider; A T Merchant; F F Fikree; M H Rahbar
Journal:  Br J Oral Maxillofac Surg       Date:  2000-02       Impact factor: 1.651

5.  Expression of proliferating cell nuclear antigen (PCNA) in oral submucous fibrosis, oral epithelial hyperkeratosis and oral epithelial dysplasia in Taiwan.

Authors:  C P Chiang; M J Lang; B Y Liu; J T Wang; J S Leu; L J Hahn; M Y Kuo
Journal:  Oral Oncol       Date:  2000-07       Impact factor: 5.337

6.  Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa.

Authors:  I Martínez-Lara; M A González-Moles; I Ruiz-Avila; M Bravo; M C Ramos; J A Fernández-Martínez
Journal:  Acta Stomatol Belg       Date:  1996-03

Review 7.  Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer.

Authors:  R Pillai; P Balaram; K S Reddiar
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

8.  A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut.

Authors:  P N Sinor; P C Gupta; P R Murti; R B Bhonsle; D K Daftary; F S Mehta; J J Pindborg
Journal:  J Oral Pathol Med       Date:  1990-02       Impact factor: 4.253

9.  Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle.

Authors:  P Kurki; M Vanderlaan; F Dolbeare; J Gray; E M Tan
Journal:  Exp Cell Res       Date:  1986-09       Impact factor: 3.905

10.  Occurrence of epithelial atypia in 51 Indian villagers with oral submucous fibrosis.

Authors:  J J Pindborg; F S Mehta; D K Daftary
Journal:  Br J Cancer       Date:  1970-06       Impact factor: 7.640

View more
  5 in total

1.  The effects of proliferating cell nuclear antigen and p53 in patients with oral squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Rui Liu; Kunjun Sun; Yuanda Wang; Yunxian Jiang; Jianyong Kang; Hong Ma
Journal:  Ann Transl Med       Date:  2021-12

2.  Expression of p63 and Proliferating Cell Nuclear Antigen in Oral Submucous Fibrosis.

Authors:  S Suwasini; Manisha Shrikaar; Nishu Kumari; Abhishek Singh; Khusboo Kumari; Madhuresh Kumar
Journal:  J Int Soc Prev Community Dent       Date:  2021-07-30

Review 3.  Pre-Cancerous Lesions in the Oral and Maxillofacial Region: A Literature Review with Special Focus on Etiopathogenesis.

Authors:  Soussan Irani
Journal:  Iran J Pathol       Date:  2016

4.  Bone Marrow-Derived Mesenchymal Stem Cell Potential Regression of Dysplasia Associating Experimental Liver Fibrosis in Albino Rats.

Authors:  Yasmine H Khalifa; Ghada M Mourad; Wahid M Stephanos; Sahar A Omar; Radwa A Mehanna
Journal:  Biomed Res Int       Date:  2019-11-06       Impact factor: 3.411

Review 5.  Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.

Authors:  Yen-Wen Shen; Yin-Hwa Shih; Lih-Jyh Fuh; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.